Novo Nordisk (NVO) slashed the price of its weight-loss blockbuster, Wegovy, by more than half on Wednesday amid a bitter rivalry with pharmaceutical compounder Hims & Hers Health (HIMS).
Novo N… [+2935 chars]
Novo Slashes Wegovy Price, Undercutting Its Most Bitter Rival - Investor's Business Daily
The news slammed Hims stock. Hims & Hers sells knockoff versions of semaglutide, the chemical backbone behind Wegovy.
By:ALLISON GATLIN, Investor's Business Daily
Source:Investor's Business Daily
Published:
Related News
business
businessbusiness
Stock Market Today: Dow Drops; Intel Stock Slides; Gold Hits Record — Live Updates - The Wall Street Journal
The Wall Street Journal•The Wall Street Journal
Is China quietly winning the AI race? - BBC
The BBC's Lily Jamali looks into why big US firms and start-ups alike are turning to Chinese tech.
BBC News
Why the dollar just had its worst week in 8 months despite Trump’s pivot on tariffs - MarketWatch
MarketWatch•MarketWatch